Treatment patterns and outcomes of older patients with mantle cell lymphoma in an Asian population

Treatment patterns and outcomes of older patients with mantle cell lymphoma in an Asian population

Abstract Background Significant progress has been made in the treatment outcomes of mantle cell lymphoma (MCL) since the introduction of cytarabine and rituximab in modern regimens. However, older patients may not readily tolerate these agents nor derive benefit. We investigated the impact of age on...

Full description

Bibliographic Details
Main Authors: Xinyi Yang, Lay Poh Khoo, Esther Wei Yin Chang, Valerie Shiwen Yang, Eileen Poon, Nagavalli Somasundaram, Mohamad Farid, Tiffany Pooi Ling Tang, Miriam Tao, Soon Thye Lim, Jason Yongsheng Chan
Format: Article
Language:English
Published: BMC 2021-05-01
Series:BMC Cancer
Subjects:
Prognostic biomarker
Cytarabine
Non-Hodgkin lymphoma
Chemotherapy
Online Access:https://doi.org/10.1186/s12885-021-08326-1

Internet

https://doi.org/10.1186/s12885-021-08326-1

Similar Items